MUFG Securities EMEA’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,000
Closed -$518K 165
2022
Q1
$518K Hold
10,000
0.01% 103
2021
Q4
$591K Hold
10,000
0.01% 139
2021
Q3
$430K Buy
+10,000
New +$443K ﹤0.01% 247
2021
Q2
Sell
-10,000
Closed -$362K 390
2021
Q1
$362K Hold
10,000
﹤0.01% 327
2020
Q4
$368K Sell
10,000
-540
-5% -$19.8K ﹤0.01% 347
2020
Q3
$367K Buy
+10,540
New +$370K ﹤0.01% 348
2020
Q2
Sell
-1,054,000
Closed -$32.6M 482
2020
Q1
$32.6M Hold
1,054,000
0.33% 57
2019
Q4
$39.2M Hold
1,054,000
0.31% 70
2019
Q3
$35.9M Buy
+1,054,000
New +$38.3M 0.43% 48
2019
Q2
Sell
-10,540
Closed -$425K 496
2019
Q1
$425K Hold
10,540
﹤0.01% 440
2018
Q4
$437K Hold
10,540
﹤0.01% 357
2018
Q3
$441K Buy
+10,540
New +$406K 0.01% 491
2015
Q3
Sell
-316,200
Closed -$10.1M 122
2015
Q2
$10.1M Buy
+316,200
New +$10.3M 1.67% 12

Other funds holding PFE

MUFG Securities EMEA's PFE Position: Q2 2026 in Review

MUFG Securities EMEA reduced its Pfizer (PFE) stake by 4.3% in Q2 2026, selling an estimated $264K and leaving 223,079 shares worth $5.37M. The position accounts for 0.06% of the portfolio, ranked #199.

MUFG Securities EMEA first reported a position in PFE in Q1 2014 and has held it in 36 quarters since. The position peaked at $114M in Q4 2017. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • MUFG Securities EMEA held 223,079 shares of Pfizer worth $5.37M as of Q2 2026.
  • MUFG Securities EMEA sold 10,080 Pfizer shares in Q2 2026, an estimated $264K.
  • Pfizer made up 0.06% of MUFG Securities EMEA's portfolio in Q2 2026, its #199 holding.
  • MUFG Securities EMEA first reported a position in Pfizer in Q1 2014 and has held it in 36 quarters since.
  • MUFG Securities EMEA's Pfizer position peaked at $114M in Q4 2017.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on MUFG Securities EMEA's 13F filing for Q2 2026, filed 12 Aug 2026.